To enhance our comprehension of how NS3 impacts liver cancer cells, we initially developed two human HCC cell lines with a stable expression of NS3 protein (HCCLM3‐NS3 and Huh‐7‐NS3). The gene discussed is KRAS; the disease is hepatocellular carcinoma.